Long Term Debt Summary of Hadasit Bio-Holdings Ltd

Hadasit Bio-Holdings Ltd's latest annual long term debt in 2023 was - ILS , down -100.0% from previous year.
Hadasit Bio-Holdings Ltd's latest quarterly long term debt in 2024 Q1 was - ILS , down 0.0% from previous quarter.
Hadasit Bio-Holdings Ltd reported annual long term debt of 1.4 Million ILS in 2022, down 0.0% from previous year.
Hadasit Bio-Holdings Ltd reported annual long term debt of - ILS in 2021, down -100.0% from previous year.
Hadasit Bio-Holdings Ltd reported quarterly long term debt of - ILS for 2024 Q1, down 0.0% from previous quarter.
Hadasit Bio-Holdings Ltd reported quarterly long term debt of 1.54 Million ILS for 2023 Q1, up 9.3% from previous quarter.

Annual Long Term Debt Chart of Hadasit Bio-Holdings Ltd (2023 - 2012)

Historical Annual Long Term Debt of Hadasit Bio-Holdings Ltd (2023 - 2012)

Year	Long Term Debt	Long Term Debt Growth
2023	- ILS	-100.0%
2022	1.4 Million ILS	0.0%
2021	- ILS	-100.0%
2020	1.46 Million ILS	0.0%
2019	- ILS	0.0%
2018	- ILS	0.0%
2017	- ILS	0.0%
2016	- ILS	-100.0%
2015	1.08 Million ILS	-14.33%
2014	1.26 Million ILS	0.0%
2013	- ILS	0.0%
2012	- ILS	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	- ILS	0.0%
2024 Q1	- ILS	0.0%
2023 Q1	1.54 Million ILS	9.3%
2023 Q4	- ILS	0.0%
2023 FY	- ILS	-100.0%
2023 Q3	- ILS	-100.0%
2023 Q2	1.54 Million ILS	0.0%
2022 Q2	- ILS	0.0%
2022 FY	1.4 Million ILS	0.0%
2022 Q4	1.4 Million ILS	0.0%
2022 Q3	1.4 Million ILS	0.0%
2022 Q1	- ILS	0.0%
2021 FY	- ILS	-100.0%
2021 Q4	- ILS	0.0%
2021 Q2	- ILS	0.0%
2021 Q3	- ILS	0.0%
2021 Q1	- ILS	-100.0%
2020 FY	1.46 Million ILS	0.0%
2020 Q2	- ILS	0.0%
2020 Q3	1.46 Million ILS	0.0%
2020 Q4	1.46 Million ILS	0.0%
2020 Q1	- ILS	0.0%
2019 Q3	- ILS	0.0%
2019 Q4	- ILS	0.0%
2019 Q1	- ILS	0.0%
2019 FY	- ILS	0.0%
2019 Q2	- ILS	0.0%
2018 Q1	- ILS	0.0%
2018 FY	- ILS	0.0%
2018 Q3	- ILS	0.0%
2018 Q2	- ILS	0.0%
2018 Q4	- ILS	0.0%
2017 FY	- ILS	0.0%
2017 Q1	- ILS	0.0%
2017 Q2	- ILS	0.0%
2017 Q3	- ILS	0.0%
2017 Q4	- ILS	0.0%
2016 Q4	- ILS	0.0%
2016 FY	- ILS	-100.0%
2016 Q3	- ILS	-100.0%
2016 Q2	1.19 Million ILS	7.28%
2016 Q1	1.11 Million ILS	2.77%
2015 Q1	1.28 Million ILS	1.58%
2015 Q4	1.08 Million ILS	-1.46%
2015 Q2	980 Thousand ILS	-23.62%
2015 Q3	1.09 Million ILS	12.04%
2015 FY	1.08 Million ILS	-14.33%
2014 FY	1.26 Million ILS	0.0%
2014 Q3	1.82 Million ILS	0.0%
2014 Q2	- ILS	0.0%
2014 Q1	- ILS	0.0%
2014 Q4	1.26 Million ILS	-30.95%
2013 Q1	- ILS	0.0%
2013 Q4	- ILS	0.0%
2013 Q3	- ILS	0.0%
2013 FY	- ILS	0.0%
2013 Q2	- ILS	0.0%
2012 Q4	- ILS	0.0%
2012 FY	- ILS	0.0%

Peer Long Term Debt Comparison of Hadasit Bio-Holdings Ltd

Name	Long Term Debt	Long Term Debt Difference
Nuo Therapeutics, Inc.	164.2 Thousand USD	100.0%
CNBX Pharmaceuticals Inc.	- USD	NaN%
Mosaic ImmunoEngineering Inc.	1.22 Million USD	100.0%
Evofem Biosciences, Inc.	8000.00 USD	100.0%
GB Sciences, Inc.	322 Thousand USD	100.0%
Inhibitor Therapeutics, Inc.	- USD	NaN%
NanoSphere Health Sciences Inc.	- USD	NaN%
Skye Bioscience, Inc.	171.23 Thousand USD	100.0%
Zenith Capital Corp.	4456.00 USD	100.0%
Agentix Corp.	- USD	NaN%
Arch Therapeutics, Inc.	- USD	NaN%
Biomind Labs Inc.	- USD	NaN%
ContraFect Corporation	2.21 Million USD	100.0%
CSL Limited	11.23 Billion USD	100.0%
CytoDyn Inc.	141 Thousand USD	100.0%
GlobeStar Therapeutics Corporation	- USD	NaN%
Neon Bloom, Inc.	- USD	NaN%
Northwest Biotherapeutics, Inc.	20.31 Million USD	100.0%
ProtoKinetix, Incorporated	- USD	NaN%
Propanc Biopharma, Inc.	58.64 Thousand USD	100.0%
Regen BioPharma, Inc.	149.61 Thousand USD	100.0%
Santhera Pharmaceuticals Holding AG	1.75 Million USD	100.0%
SQZ Biotechnologies Company	20.9 Million USD	100.0%
Therapeutic Solutions International, Inc.	5512.00 USD	100.0%
Eiger BioPharmaceuticals, Inc.	- USD	NaN%
Intellipharmaceutics International Inc.	- USD	NaN%
Mesoblast Limited	100.29 Million USD	100.0%
Marizyme, Inc.	667.12 Thousand USD	100.0%
Genus plc	228.2 Million USD	100.0%
Pharming Group N.V.	166.1 Million USD	100.0%
Nymox Pharmaceutical Corporation	- USD	NaN%
RegeneRx Biopharmaceuticals, Inc.	1.4 Million USD	100.0%
IMV Inc.	27.39 Million USD	100.0%
AXIM Biotechnologies, Inc.	5.42 Million USD	100.0%
MultiCell Technologies, Inc.	36.43 USD	100.0%
ONE Bio Corp.	592.19 Thousand USD	100.0%
RVL Pharmaceuticals plc	55.61 Million USD	100.0%
Arno Therapeutics, Inc.	- USD	NaN%
Emmaus Life Sciences, Inc.	2.22 Million USD	100.0%
Provectus Biopharmaceuticals, Inc.	25.29 Thousand USD	100.0%
Oncotelic Therapeutics, Inc.	1.89 Million USD	100.0%
THC Farmaceuticals, Inc.	- USD	NaN%
Acro Biomedical Co., Ltd.	- USD	NaN%
Alpha Cognition Inc.	- USD	NaN%
Enzolytics Inc.	- USD	NaN%
MetaStat, Inc.	- USD	NaN%
argenx SE	15.35 Million USD	100.0%
Enzon Pharmaceuticals, Inc.	- USD	NaN%
Endonovo Therapeutics, Inc.	- USD	NaN%
Genscript Biotech Corporation	287.12 Million USD	100.0%
Nanobac Pharmaceuticals, Incorporated	- USD	NaN%
Institute of Biomedical Research Corp.	- USD	NaN%
Sigyn Therapeutics, Inc.	126.3 Thousand USD	100.0%
WPD Pharmaceuticals Inc.	229.29 Thousand USD	100.0%
Cotinga Pharmaceuticals Inc.	- USD	NaN%
VioQuest Pharmaceuticals, Inc.	- USD	NaN%
PsyBio Therapeutics Corp.	- USD	NaN%
Adynxx, Inc.	- USD	NaN%
Sienna Biopharmaceuticals, Inc.	- USD	NaN%
Accustem Sciences Inc.	- USD	NaN%
Helix BioMedix, Inc.	- USD	NaN%
EV Biologics, Inc.	- USD	NaN%
Q BioMed Inc.	- USD	NaN%
Capstone Therapeutics Corp.	8.26 Million USD	100.0%
American Oriental Bioengineering, Inc.	554.59 Thousand USD	100.0%
TetraLogic Pharmaceuticals Corporation	- USD	NaN%
BioStem Technologies, Inc.	265.63 Thousand USD	100.0%
Curative Biotechnology, Inc.	- USD	NaN%
HST Global, Inc.	- USD	NaN%
Burzynski Research Institute, Inc.	- USD	NaN%
Wesana Health Holdings Inc.	- USD	NaN%
Halberd Corporation	150 Thousand USD	100.0%
Resverlogix Corp.	- USD	NaN%
Cell Source, Inc.	- USD	NaN%
RespireRx Pharmaceuticals Inc.	- USD	NaN%
GeneThera, Inc.	- USD	NaN%
AVAX Technologies, Inc.	- USD	NaN%
Ember Therapeutics, Inc.	- USD	NaN%
Anthera Pharmaceuticals, Inc.	- USD	NaN%
NovAccess Global Inc.	- USD	NaN%
Kadimastem Ltd	229.69 Thousand USD	100.0%
VitaSpring Biomedical Co. Ltd.	- USD	NaN%
Rasna Therapeutics, Inc.	- USD	NaN%
Oncology Pharma Inc.	- USD	NaN%
Reve Technologies, Inc.	1064.00 USD	100.0%
LadRx Corporation	- USD	NaN%
Regen BioPharma, Inc.	149.61 Thousand USD	100.0%
Affymax, Inc.	- USD	NaN%
Itoco Inc.	- USD	NaN%
Pathfinder Cell Therapy, Inc.	- USD	NaN%
Mobile Lads Corp.	- USD	NaN%
International Stem Cell Corporation	445 Thousand USD	100.0%
Claritas Pharmaceuticals, Inc.	- USD	NaN%
Bioxytran, Inc.	- USD	NaN%
NDT Pharmaceuticals Inc.	- USD	NaN%
Qrons Inc.	80 Thousand USD	100.0%
Alseres Pharmaceuticals, Inc.	7.81 Million USD	100.0%
SYBLEU INC	300 Thousand USD	100.0%
Advanced Proteome Therapeutics Corporation	- USD	NaN%
Nascent Biotech, Inc.	- USD	NaN%
Rebus Holdings, Inc.	- USD	NaN%
ImmunoCellular Therapeutics, Ltd.	369.04 Thousand USD	100.0%
GlobeImmune, Inc.	- USD	NaN%
Predictive Technology Group, Inc.	- USD	NaN%
ProText Mobility, Inc.	- USD	NaN%
Cardax, Inc.	- USD	NaN%
VG Life Sciences Inc.	- USD	NaN%
Kaleido Biosciences, Inc.	- USD	NaN%
Advaxis, Inc.	8.15 Million USD	100.0%
Adhera Therapeutics, Inc.	- USD	NaN%
RenovaCare, Inc.	- USD	NaN%
Regnum Corp.	- USD	NaN%
Innovation Pharmaceuticals Inc.	457 Thousand USD	100.0%
Neutra Corp.	- USD	NaN%
Windtree Therapeutics, Inc.	1.16 Million USD	100.0%
PureTech Health plc	18.25 Million USD	100.0%
Coeptis Therapeutics, Inc.	150 Thousand USD	100.0%
IXICO plc	275 Thousand USD	100.0%
IntelGenx Technologies Corp.	11.83 Million USD	100.0%
Gelesis Holdings, Inc.	26.3 Million USD	100.0%
CSL Limited	11.23 Billion USD	100.0%
Cellectis S.A.	36.21 Million USD	100.0%

Global Stocks Search

Hadasit Bio-Holdings Ltd (HSITF)

Long Term Debt Summary of Hadasit Bio-Holdings Ltd

Annual Long Term Debt Chart of Hadasit Bio-Holdings Ltd (2023 - 2012)

Historical Annual Long Term Debt of Hadasit Bio-Holdings Ltd (2023 - 2012)

Peer Long Term Debt Comparison of Hadasit Bio-Holdings Ltd